Universal tumor screening for Lynch syndrome: health-care providers' perspectives.

about

Barriers to Lynch Syndrome Testing and Preoperative Result Availability in Early-onset Colorectal Cancer: A National Physician Survey Study

P2860

Q58712360-B30B4420-1796-485D-986B-1FCEDC0CA471

P2860

Universal tumor screening for Lynch syndrome: health-care providers' perspectives.

Item

http://www.wikidata.org/entity/Q39316602

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Universal tumor screening for Lynch syndrome: health-care providers' perspectives.

@en

Universal tumor screening for Lynch syndrome: health-care providers' perspectives.

@nl

type

Item

label

Universal tumor screening for Lynch syndrome: health-care providers' perspectives.

@en

Universal tumor screening for Lynch syndrome: health-care providers' perspectives.

@nl

prefLabel

Universal tumor screening for Lynch syndrome: health-care providers' perspectives.

@en

Universal tumor screening for Lynch syndrome: health-care providers' perspectives.

@nl

P1476

Universal tumor screening for Lynch syndrome: health-care providers' perspectives

@en

P2093

Anne Sorvari

http://www.w3.org/2001/XMLSchema#string

Erin Kennedy

http://www.w3.org/2001/XMLSchema#string

Linda Rabeneck

http://www.w3.org/2001/XMLSchema#string

Linda Rozmovits

http://www.w3.org/2001/XMLSchema#string

Yvonne Bombard

http://www.w3.org/2001/XMLSchema#string

P2860

EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome

The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations

Cancer risks for MLH1 and MSH2 mutation carriers.

Comparing universal Lynch syndrome tumor-screening programs to evaluate associations between implementation strategies and patient follow-through.

Facilitating informed decisions regarding microsatellite instability testing among high-risk individuals diagnosed with colorectal cancer

Whatever happened to qualitative description?

Reflex immunohistochemistry and microsatellite instability testing of colorectal tumors for Lynch syndrome among US cancer programs and follow-up of abnormal results.

Universal tumor screening for Lynch syndrome: Assessment of the perspectives of patients with colorectal cancer regarding benefits and barriers.

Stakeholder perspectives on implementing a universal Lynch syndrome screening program: a qualitative study of early barriers and facilitators.

Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives.

P2888

gim.2016.150

P304

568-574

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/GIM.2016.150

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nancy Baxter

Corinne Daly

June C Carroll

P577

2016-10-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27711070

http://www.w3.org/2001/XMLSchema#string

Universal tumor screening for Lynch syndrome: health-care providers' perspectives.

about

P2860

P2860

Universal tumor screening for Lynch syndrome: health-care providers' perspectives.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698